Recombinant factor VIIa treatment for life-threatening haemoptysis


Yildirim H. , Ucgun I., Yalcin A. U. , Gulbas Z., Sahin G. , Acikalin M. F. , ...More

RESPIROLOGY, vol.11, no.5, pp.652-654, 2006 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 5
  • Publication Date: 2006
  • Doi Number: 10.1111/j.1440-1843.2006.00906.x
  • Title of Journal : RESPIROLOGY
  • Page Numbers: pp.652-654

Abstract

Diffuse alveolar haemorrhage is a severe clinical disorder that may be life-threatening. The early diagnosis of diffuse alveolar haemorrhage and prompt intervention is crucial. Recombinant factor VIIa has been used extensively for the treatment of haemophilia A and B patients. More recently, recombinant factor VIIa has been used successfully for the treatment of bleeding in patients without pre-existing coagulopathy We describe the successful use of recombinant factor VIIa in a patient with diffuse alveolar haemorrhage secondary to pulmonary-renal syndrome.